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Abstract
Background: Protein kinase CK2 is a pleiotropic serine/threonine protein kinase with hundreds of reported
substrates, and plays an important role in a number of cellular processes. The cellular functions of Plasmodium
falciparum CK2 (PfCK2) are unknown. The parasite’s genome encodes one catalytic subunit, PfCK2a, which we have
previously shown to be essential for completion of the asexual erythrocytic cycle, and two putative regulatory
subunits, PfCK2b1 and PfCK2b2.
Results: We now show that the genes encoding both regulatory PfCK2 subunits (PfCK2b1 and PfCK2b2) cannot be
disrupted. Using immunofluorescence and electron microscopy, we examined the intra-erythrocytic stages of
transgenic parasite lines expressing hemagglutinin (HA)-tagged catalytic and regulatory subunits (HA-CK2a, HA-
PfCK2b1 or HA-PfCK2b2), and localized all three subunits to both cytoplasmic and nuclear compartments of the
parasite. The same transgenic parasite lines were used to purify PfCK2b1- and PfCK2b2-containing complexes,
which were analyzed by mass spectrometry. The recovered proteins were unevenly distributed between various
pathways, with a large proportion of components of the chromatin assembly pathway being present in both
PfCK2b1 and PfCK2b2 precipitates, implicating PfCK2 in chromatin dynamics. We also found that chromatin-related
substrates such as nucleosome assembly proteins (Naps), histones, and two members of the Alba family are
phosphorylated by PfCK2a in vitro.
Conclusions: Our reverse-genetics data show that each of the two regulatory PfCK2 subunits is required for
completion of the asexual erythrocytic cycle. Our interactome study points to an implication of PfCK2 in many
cellular pathways, with chromatin dynamics being identified as a major process regulated by PfCK2. This study
paves the way for a kinome-wide interactomics-based approach to elucidate protein kinase function in malaria
parasites.
Background
Malaria, a disease caused by parasitic protozoa of the
genus Plasmodium (phylum Apicomplexa), is responsible
for the death of one million people every year, mostly chil-
dren living in sub-Saharan Africa [1]. The burden of mor-
bidity and mortality inflicted by this disease presents a
serious hindrance to socioeconomic development, causing
up to a 1.3% decrease in the gross domestic product of
countries with a high malaria rate [2]. The number of
deaths due to malaria doubled in the last two decades of
the 20th century, with one of the primary reasons being
the spread of parasite resistance to anti-malarial drugs,
especially chloroquine [3]. Artemisinin combination ther-
apy (ACT) has helped to reverse this trend, but the worry-
ing appearance in southeast Asia of parasite isolates with
reduced artemisinin sensitivity suggests that this may be a
short-lived respite [4,5]. The development of anti-malarial
drugs with novel modes of action remains an urgent
priority.
Reversible phosphorylation is an integral part of many
cellular processes, and perturbations in its regulation
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have been identified in many diseases, such as cancer,
diabetes and rheumatoid arthritis [6,7]. Protein kinases
(PKs) are therefore attracting much interest as potential
drug targets, and recent successes in cancer chemother-
apy based on kinase inhibitors indicate that these mole-
cules can perform as drugs with appropriate selectivity,
potency and pharmacokinetic properties [8]. Investiga-
tions of the druggability of the genome identified serine/
threonine PKs as one of the most promising groups for
future small molecule inhibitors, comprising up to 20%
of the druggable genome [9].
Protein kinase CK2 (thereafter called CK2) is a pleiotro-
pic serine/threonine PK, with over 300 substrates identi-
fied in mammalian cells [10] and documented roles in
multiple cellular processes, including differentiation, pro-
liferation, survival, translation, apoptosis, transformation,
tumorigenesis, RNA synthesis, cell cycle progression, cell
morphology and polarity, cellular responses to stress and
to DNA damage, and circadian rhythm [11,12]. The
enzyme phosphorylates a range of DNA-binding proteins,
nuclear oncoproteins, and transcription factors [13], and
several studies have highlighted the predominance of CK2
substrates involved in transcription, chromatin structure,
and gene expression [10,12,14]. Taken together, these stu-
dies highlight transcriptional regulation as one of the
major roles of the enzyme [15]. Controlled cellular com-
partmentalization is crucial for the function of a pleiotro-
pic enzyme such as CK2, and substrate selection is
presumably dependent on proper targeting [12]. Although
predominantly nuclear [16], mammalian CK2 has also
been found in the cytoplasm, in association with a number
of organelles such as the Golgi apparatus, endoplasmic
reticulum, and ribosomes [17], and plant chloroplasts [18].
The human genome contains two genes encoding catalytic
(a and a’) subunits, and a single gene encoding a regula-
tory (b) subunit. CK2 is present in human cells as a tetra-
meric complex comprising two identical b subunits and
two catalytic subunits, which can be assembled in a a/a,
a/a’ or a’/a’ configuration. CK2a has been found to be
essential for viability in all organisms in which its role has
been assessed, including P. falciparum [19]. The require-
ment for viability of the b subunits of CK2 varies across
species: disruption of the single metazoan b subunit is
lethal in mice [20] and Caenorhabditis elegans [21],
whereas disruption of either or both of the b subunits in
Saccharomyces cerevisiae is not lethal [14,22,23].
Phylogenetic analysis of P. falciparum PKs [24,25]
identified a CK2a ortholog and two putative CK2b subu-
nits, PfCK2b1 and PfCK2b2 (see Holland et al. [19] for
alignments with CK2 subunits form other organisms).
The stoichiometry of the PfCK2 complexes is not known;
by analogy with other systems, it is hypothesized that a
homo- or heterodimer of b subunits is complexed with
two catalytic subunits in the holoenzyme, but this still
requires experimental demonstration. Using transcrip-
tomics, it has been shown that all three subunits are
expressed throughout the asexual erythrocytic asexual
cycle, in gametocytes and in sporozoites [26,27]. Proteo-
mics data available for PfCK2a and PfCK2b1 indicate
that both proteins are present in the asexual erythrocytic
stages and gametocytes, and that the a subunit is also
present in sporozoites [28]. We showed previously that
PfCK2a is essential for completion of the erythrocytic
asexual cycle [19], but neither the requirement of the b
subunits for viability nor the cellular processes implicat-
ing the enzyme have been assessed.
In the current study, we used a reverse-genetics
approach, and found that both regulatory subunits are also
essential for intra-erythrocytic asexual proliferation.
Reasoning that identifying interactors of the regulatory
subunits might provide useful insight into the cellular func-
tions of the PfCK2 holoenzyme, we analyzed the protein
composition of complexes obtained by co-immunoprecipi-
tation of PfCK2b1 or PfCK2b2 from transgenic parasite
lines expressing tagged subunits. This allowed us to recover
proteins involved in many cellular processes, consistent
with our immunofluorescence assay (IFA) data localizing
the kinase subunits to both nuclear and cytoplasmic com-
partments. To investigate the role of CK2 in gene regula-
tion specifically, we focused validation experiments on
nuclear proteins, and found that several proteins involved
in chromatin dynamics, which were recovered in the b sub-
unit pull-downs, are substrates for PfCK2a in vitro. Taken
together, our data identify PfCK2 as an essential kinase
involved in chromatin dynamics.
Results
Both of the CK2b subunits play crucial roles in the
erythrocytic asexual cycle
We first aimed to determine whether PfCK2 b subunits
play essential functions in parasite proliferation. CK2b
proteins possess two conserved pairs of cysteine residues
that form the base of a zinc finger required for homo- and
heterodimerization [29], a prerequisite for CK2 holoen-
zyme formation [30]. To generate plasmids able to disrupt
pfck2b genes, an internal fragment of the coding sequence
excluding those crucial motifs was amplified and cloned
into the transfection vector pCAM-BSD, which confers
resistance to blasticidin [31]. It was expected that integra-
tion of the constructs (pCAM-BSD-KOPfCK2b1 and
pCAM-BSD-KOPfCK2b2) into their cognate genomic loci
by single crossover homologous recombination would
result in a pseudo-diploid configuration, in which both
truncated copies would be unable to express a functional
protein (Figure 1A). After two independent transfections
of pCAM-BSD-KOPfCK2b1 into 3D7 parasites, integra-
tion was monitored by PCR in the blasticidin-resistant
populations (Figure 1B; see Additional file 1, table A1, for
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a list of all primers used in this study), using primer com-
binations that allow discrimination between the episome,
the wild-type locus, and the disrupted locus. Only the epi-
some (lane 3) and the wild-type locus (lane 1) were detect-
able, with no sign of integration even after prolonged
culture (15 weeks). This might be due either to the fact
that pfck2b1 is essential to the completion of the asexual
parasite cycle, or to the possible refractoriness of the locus
to recombination.
To ascertain whether pfckb1 can be disrupted if the
subunit is provided through expression of an episomal
copy of the gene, we constructed a complementation
Primers Expected size of
amplified band (bp)
Wild type (lane 1) 1 + 2 934
5’ integration (lane 2) 1 + 4 598
Plasmid (lane 3) 3 + 4 604
Figure 1 Reverse genetics of PfCK2b1. 3D7 parasites transfected with pCAM-BSD-KOPfCK2b1 with or without pCHD-PfCK2b1 were analyzed by
PCR and Southern blotting. (A) Locations of the primers used for PCR screening, and the restriction enzymes used to cut the genomic DNA to
give a diagnostic pattern of bands for analysis by Southern blotting. One truncated copy possesses its promoter and initiation codon, but lacks
the C-terminal cysteine pair, a stop codon and a 3’UTR, whereas the other copy possesses both cysteine pairs but lacks a promoter and an
initiation codon, and has an artificial stop codon introduced. (B) PCR screening of DNA from untransfected 3D7 parasites, two separate pCAM-
BSD-KOPfCK2b1-transfected lines (KOCK2b1 1 and KOCK2b1 2), and parasites transfected with both the knockout plasmid and the
complementation plasmid (KOCK2b1 + comp). (1) Amplification of the wild-type locus; (2) amplification over the 5’ integration boundary; (3)
amplification of the insert in the pCAM-BSD-KOPfCK2b1 plasmid. Evidence of integration was seen only in the DNA from the doubly transfected
parasite culture (KOCK2b1 + comp; lane 2, faint band seen at 598 bp). (C) The parasite DNA was digested using the restriction enzymes EcoRI
and ClaI, and analyzed by Southern blotting, using BSD and PfCK2b1 sequences as probes. (1) Untransfected 3D7; (2) KOCK2b1 1; (3) KOCK2b1 2;
(4) KOCK2b1 + complement. See text for details.
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plasmid (pCHD-PfCK2b1) containing the full-length
pfckb1 gene under the control of the PfHsp86 promoter
and a 3’ UTR. In parallel with the transfection of the
pCAM-BSD-KOPfCK2b1 plasmid alone, a population of
parasites was transfected with both pCAM-BSD-
KOPfCK2b1 and pCHD-PfCK2b1. PCR (Figure 1B) and
Southern blot (Figure 1C) analyses showed that disrup-
tion of the targeted locus occurred only in this doubly
transfected, doubly resistant parasite culture. Probing
the membrane with a BSD probe (Figure 1C, left panel)
confirmed that integration had occurred only in the
parasites transfected with both the knockout and com-
plementation plasmids. The pfckb1 probe hybridized to
the 11.1 kb band, corresponding to the wild-type locus,
in the lane that contained DNA from untransfected
parasites and from parasites transfected with the knock-
out plasmid alone (lanes 1 to 3). This band was unde-
tectable in DNA from parasites transfected with both
the knockout and complementation plasmid (lane 4),
indicating that the gene can be disrupted only when an
additional cassette coding for the PfCK2b1 subunit is
provided to the parasites. There are multiple possibilities
for recombination of the knockout and complementa-
tion plasmids before or after integration, which presum-
ably accounts for the additional bands. The crucial
observation is the disappearance of the wild-type-speci-
fic band only in the doubly transfected parasite culture.
Similar results were obtained for PfCK2b2 (see Addi-
tional file 2, Figure A1), indicating that both regulatory
subunits play crucial roles in parasite proliferation in
the red blood cell.
PfCK2 subunits localize to both cytoplasmic and nuclear
compartments
To generate parasite lines expressing tagged PfCK2b1 or
PfCK2b2 from the endogenous loci, we transfected wild-
type parasites with 3’-HA-tagged constructs (pCAM-
BSD-HA-pfck2b1 or pCAM-BSD-HA-pfck2b2), which
were expected not to cause loss of function of the target
protein upon integration into the cognate locus. Integra-
tion of the tagging construct and disappearance of the
wild-type locus were readily achieved for both genes (see
2 file 5, Figure A2, Figure A3). To determine the subcel-
lular localization of HA-tagged PfCK2a [19], PfCK2b1 or
PfCK2b2 subunits, we examined these transgenic lines in
IFAs using antibodies against the HA epitope and against
Exp2, a parasitophorous vacuole marker [32] (data for
localization of all three subunits are presented in Figure
2A-C). In line with the pleiotropic nature of CK2 in
eukaryotic cells, a signal for all three subunits was detect-
able in both the cytoplasmic and nuclear compartments
of the parasite. The location of HA-tagged PfCK2a and
PfCK2b2 in rings, trophozoites, and schizonts was further
examined by immuno-electron microscopy, which
confirmed presence of the protein in both cytoplasm and
nucleus (Figure 3). Furthermore, bands of the expected
sizes of all three subunits were clearly visible on anti-HA
western blots in both cytoplasmic and nuclear fractions
of unsynchronized cultures of the three HA-tagged para-
site lines (Figure 2D). Antibodies against aldolase, a cyto-
plasmic marker, and against histone H3, a nuclear
marker, were used to probe the same western-blot mem-
brane to ascertain the purity of the subcellular fractions
(Figure 2E). In conclusion, our data suggest that PfCK2
subunits are expressed throughout erythrocytic schizog-
ony, and are present in various subcellular locations.
Purification and mass spectrometry analysis of protein
complexes involving the PfCK2b subunits
To gain insight into the functions of PfCK2 through iden-
tification of the proteins with which the holoenzyme inter-
acts, we subjected protein extracts from the parasite line
expressing HA-tagged PfCK2b1 to immunoprecipitation
using the anti-HA antibody; the same analysis was per-
formed on extracts from wild-type parasites as a negative
control. The immunoprecipitates were separated by SDS-
PAGE, and a western blotting was performed using anti-
PfCK2b1 to verify the immunoprecipitation efficiency (see
Additional file 2, Figure A4A). A parallel gel was loaded
and slices excised (see Additional file 2, Figure A4B) for
mass spectrometry analysis.
Potential interactors (see Additional file 3, Table A2)
were identified based on the number of unique peptides
recovered, and on the unweighted spectrum count of the
number of detected peptides. We considered proteins as
potential hits if they were present in the immunoprecipi-
tate from the HA-tagged line but were absent (or present
in trace amounts only) in those from the wild-type para-
sites. The same experiment was performed in parallel with
the parasite line expressing HA-tagged PfCK2b2 (see
Additional file 4, Table A3, for the list of recovered pro-
teins), although in this case we were unable to perform
western-blot verification of the immunoprecipitate
because of the poor quality of the anti- PfCK2b2 antibody.
PfCK2a was pulled down with both HA-PfCK2b1 and
HA-PfCK2b2, in line with the previously reported in
vitro interaction between the catalytic subunit and both
regulatory subunits [19]. Interestingly, PfCK2b1 and
PfCK2b2 were present in similar amounts in both immu-
noprecipitates, suggesting that complexes containing
both regulatory subunits may be relatively abundant.
We examined the distribution of all other potential
interactors among the various parasite metabolic processes
described in the Malaria Parasite Metabolic Pathways
(MPMP) website (curated by H. Ginsburg; http://sites.huji.
ac.il/malaria/) (Figure 4, top panel). Although some path-
ways were not represented at all in the
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immunoprecipitates, or had only a very small number of
entries, others displayed many hits in both lists.
A different distribution pattern was seen when the
same protocol, using the same anti-HA antibody, was
applied to parasites expressing other HA-tagged kinases,
such as PfCK1 (data not shown); this result lends sup-
port to the specificity of the pull-down approach. For
both PfCK2b subunits, the highest numbers of potential
interactors were found in the processes of 1) post-trans-
lational modifications, and 2) mitosis and chromosome
separation. As we were aiming to understand the
nuclear function of PfCK2, we focused further investiga-
tions on the latter process.
Each metabolic process covers several specific path-
ways. Of the various pathways grouped under the ‘mitosis
and chromosome separation’ process, some contained
very few or no hits (Figure 4, bottom panel). By contrast,
12 proteins belonging to the ‘nucleosome assembly and
regulation pathway’ (see Additional file 2, Figure A5)
were found in the PfCK2b immunoprecipitates (Table 1).
These included both P. falciparum nucleosome assembly
proteins PfNapL (PFL0185c) and PfNapS (PFI0930c). Co-
immunoprecipitation experiments coupled to western-
blot analysis established that HA-tagged PCK2a can also
pull down both PfNaps (see Additional file 2, Figure A6).
Naps are negatively charged proteins that act as histone
chaperones and function as histone depositors, allowing
ordered formation of chromatin at definite sites. PfNapL
and PfNapS proteins interact in vitro with P. falciparum
histones H2A, H2B, H3, and H4, and are in vitro sub-
strates for human CK2 [33,34]. A number of histones
and their variants, and several proteins thought to be
involved in virulence-gene regulation through association
with sub-telomeric chromatin at the nuclear periphery,
Figure 2 Localization of PfCK2 subunits over the life cycle of the blood-stage parasite. (A-C) Hemagglutinin (HA)-tagged PfCK2 subunits
(green) localized to both nuclear and cytoplasmic compartments in rings, trophozoites and schizonts. The limits of the parasitophorous vacuole
membrane (PVM) are marked by Exp-2 (red). (D) HA-tagged PfCK2 subunits were detected in both the cytoplasmic and nuclear fraction.
Western-blot analysis was performed on the cytoplasmic (C) and nuclear (N) fraction of unsynchronized PfCK2a, PfCK2b1, and PfCK2b2 parasites
using anti-HA antibody, which gave bands in both the fractions. Predicted molecular weights of the proteins are: PfCK2a, 39.8 kDa; PfCK2b1, 28.3
kDa; PfCK2b2, 45.2 kDa. (E) The same C and N fractions were probed with antibodies against aldolase, a cytoplasmic marker, and histone H3, a
nuclear marker, to assess the purity of the fractions. Aldolase gave a band at 40 kDa in the cytoplasmic fractions only, whereas the histone H3
band at 17 kDa was seen only in the nuclear fractions.
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were also identified in the b subunit precipitates. These
included two of the four Alba P. falciparum proteins that
have recently been identified as perinuclear DNA-RNA-
binding proteins and thought to play a role in gene regu-
lation in asexual stages [35]; the prototype Alba protein
was described as an archeal chromatin protein [36].
P. falciparum Naps, histones and Alba proteins are
substrates for PfCK2a in vitro
We tested whether recombinant PfCK2a could phos-
phorylate selected chromatin-associated proteins from
the potential PfCK2b interactor list. Kinase assays were
performed with glutatione S-transferase (GST)-tagged
 
Figure 3 Immuno-electron microscopy of the hemagglutinin (HA)-tagged PfCK2a and PfCK2b2 subunits. Immuno-electron microscopy
was performed with an anti-HA antibody on ring-, trophozoite- and schizont-stage parasites from the HA-tagged lines. HA-PfCK2a and HA-
PfCK2b2 localized to both cytoplasmic and nuclear compartments in accordance with our IFA and western-blot data.
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PfCK2a, using a GST-PfCK2a K72M dead mutant as a
negative control (Figure 5). PfCK2a autophosphorylation
generated a band of ~60 kDa in size, but the dead
mutant did not autophosphorylate, and was unable to
phosphorylate exogenous substrates, as previously
reported [19]. When subjected to a kinase assay using
PfCK2a, both recombinant PfNaps were phosphorylated,
with PfNapL (55 kDa) giving a very strong signal (after
as short an exposure time as 30 minutes), and PfNapS
(37 kDa) appearing as a much less efficient substrate
Figure 4 Potential interactors in various metabolic processes. (A) Histogram representing the number of potential PfCK2b interactors
distributed among the metabolic processes described in the Metabolic Pathways of Malaria Parasites website http://sites.huji.ac.il/malaria/. (B)
Potential interactors in the post-translational modification pathways and the mitosis and chromosome separation pathway. The nucleosome
assembly and regulation pathway contained a higher number of proteins co-precipitating with the CK2 regulatory subunits.
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(even after a longer exposure time of 2 hours) (Figure
5A). No phosphorylation of the Nap proteins was seen,
either with the PfCK2 kinase-dead-mutant control, nor
with the unrelated PK PfPK6 [37,38], despite the ability
of the latter enzyme to autophosphorylate and to phos-
phorylate myelin basic proteins in our assay conditions
(Figure 5D).
We next examined the ability of histones to act as
substrates for recombinant GST-PfCK2a. Recently, sev-
eral phosphorylation sites in plasmodial histones have
been identified ([39]; Dastidar et al., unpublished data),
and because several histones were recovered in the
PfCK2b precipitates (Table 1), we thought that PfCK2a
might be one of the kinases that can phosphorylate his-
tones. When purified parasite native histones were sub-
jected to a GST-PfCK2a kinase assay, preferential
phosphorylation of histone H2B (13 kDa) was seen,
whereas the dead-mutant kinase failed to phosphorylate
any of the histones (Figure 5B). We also tested in
PfCK2a kinase assays all four P. falciparum Alba mem-
bers expressed as GST fusion proteins [35], as well as
the nuclear protein PfSir2, which is implicated in estab-
lishment of heterochromatin in sub-telomeric region
and hence represses var gene expression [40-42].
PfAlba3, PfAlba4, and Sir2 were not phosphorylated by
GST-PfCK2a (Figure 5E). By contrast, PfAlba1 (55 kDa)
and PfAlba2 (52 kDa) gave signals on the autoradio-
graphs after a kinase assay was performed with GST-
PfCK2a, whereas none of the substrates subjected to the
GST-PfCK2a dead mutant was phosphorylated (Figure
5C).
Discussion
Our reverse-genetics data strongly suggest that both
PfCK2b subunits are essential for parasite viability, indi-
cating that they have non-redundant functions in the
parasite. This was unexpected given the dispensability of
the b subunits for viability in S. cerevisiae (which has two
CK2b subunits that can be knocked out individually or
simultaneously [14,22,23]) and ib Schizosaccharomyces
pombe (which had a single b subunit) [43]. However, the
single b subunit present in C. elegans [21] and in mice
[20] is essential. The different interactomes for the CK2b
subunits in S. cerevisiae [44] are consistent with func-
tional specialization of each b subunit. The immunopre-
cipitates obtained with PfCK2b1 and PfCK2b2, despite
displaying significant overlap in the identity of recovered
proteins, also contained hits that were found in only one
Table 1 Potential interactors in the nucleosome assembly and regulation pathway.a
Proteinb PlasmoDB PfCK2b1HA (3D7/tagged)c PfCK2b2HA (3D7/tagged)c
PfCK2a MAL13P1.237 1/161 1/188
PfCK2b1 PF11_0048 1/31 1/24
PfCK2b2 PF13_0232 0/37 0/33
PfNapL PFL0185c 0/3 0/3
PfNapS PFI0930c 0/4 0/2
Histone H2A PFF0860c 0/35 Xd
Histone H2A variant PFC0920w 2/25 2/6
Histone H2B PF11_0062 2/11 2/3
Histone H2B variant PF07_0054 0/4 X
Histone H3 PFF0510w 3/13 3/5
Hhistone H4 PF11_0061 2/11 X
High mobility group protein MAL8P1.72 0/2 X
Chromodomain helicase DNA-binding protein PF10_0232 0/3 0/6
Smarca-related protein PFF1185w 0/8 0/2
Structure-specific recognition protein PF14_0393 0/2 X
PfAlba1 PF08_0074 6/12 6/7
PfrAlba2 MAL13P1.233 0/2 X
PfAlba3 MAL13P1.237 2/9 2/4
PfAlba4 PF10_0063 2/6 X
aProteins found in the HA-PfCK2b1 and HA-PfCK2b2 immunoprecipitates, which are part of the ‘nucleosome assembly and regulation pathway’ described in the
MPMP website, or have been implicated in chromatin dynamics.
bData are taken from Additional Tables A2 and A3, which display the entire list of recovered proteins.
cFor each column, the unweighted spectrum count is given first for the immunoprecipitate obtained from 3D7 wild-type parasite, and then from the transgenic
parasites expressing HA-tagged PfCK2b1or PfCK2b2.
dX signifies that the protein was not found in the immunoprecipitate.
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of the two immunoprecipitates (see Additional file 5,
Table A4). This would be consistent with the non-redun-
dancy in function suggested by reverse genetics; however,
we do not have sufficient data to draw any firm conclu-
sion in this respect. The dataset presented in the supple-
mentary material (see Additional file 3, Table A2; see
 
Figure 5 PfNaps, histones and PfAlba are substrates for recombinant PfCK2a. In vitro kinase assays were performed on purified native
parasite histones and recombinant PfNapL, PfNapS, four members of the PfAlba gene family, and Sir2, using active GST-PfCK2a and with a GST-
PfCK2a K72M dead mutant. The PfCK2a kinase yielded an autophosphorylation band at 60 kDa, whereas the kinase-dead mutant did not yield
any signal with any of the tested substrates. (A) GST-PfCK2a phosphorylates PfNapS and PfNapL, with PfNapL giving a much stronger signal.
(Left and middle): active GST-PfCK2a; (right): kinase-dead GST-PfCK2a K78M mutant. (B) GST-PfCK2a specifically phosphorylated histone H2B
(right panel, left lane) in a mixture of native histones purified from the parasite (left panel: Coomassie stain of the purified native histones used
for the assay). The PfCK2a kinase-dead mutant did not yield any signal. (C) GST-PfCK2a phosphorylated PfAlba1 and PfAlba2 GST fusion proteins,
producing signals at 53 and 51 kDa respectively (left panel, bottom bands). (Left panel) Active GST-PfCK2a; (right panel) kinase-dead GST-PfCK2a
K78M mutant. (D) His-PfPK6 wass unable to phosphorylate PfNapS and PfNapL, but autophosphorylates and phosphorylates MBP. (E) GST-PfCK2a
is unable to phosphorylate PfAlba3, PfAlba4, and Sir2 GST fusion proteins. Only the GST-PfCK2a autophosphorylation band was visible.
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Additional file 4, Table A3) is from one of three experi-
ments. Although several hits obtained in the first dataset
were confirmed in two further experiments, fewer pro-
teins were recovered in the latter, pre-empting statistical
analysis, More work is needed to confirm that individual
proteins are truly absent from one of the other PfCK2b
interactome. However, the data (see Additional file 3,
Table A2; see Additional file 4, Table A3) nevertheless
enabled us to propose assignment of specific functions to
PfCK2.
Using recombinant proteins in pull-down experiments,
we previously found that PfCK2a is able to interact with
both b subunits in vitro [19]. MS analysis of immuno-
precipitated subunits (this study) indicates that these
interactions are also found in parasite extracts. CK2 is
known to have several functions in various organisms
[11,12], and the glimpse into the interactomes of the P.
falciparum CK2 regulatory subunits provided by our
study is consistent with their involvement in a number
of cellular processes. Implementing the same protocol
with different HA-tagged kinases such as PfCK1 (data
not shown) yielded protein repertoires that were clearly
distinct from those described here for the PfCK2b subu-
nits, lending support to the specificity of the approach.
Potential PfCK2 interactors were found in 17 out of 18
metabolic processes described on the MPMP website.
Many processes displayed only a very small number of
hits; whether or not these represent genuine interactors
will require in-depth investigations of each individual
case.
By contrast, other processes and pathways exhibited a
large proportion of their proteins recovered in the immu-
noprecipitates, suggesting that a number of distinct func-
tional complexes had been pulled down. A striking
example is the ‘nucleosome assembly and regulation’
pathway, many components of which were found in both
PfCK2b1 and PfCK2b2 immunoprecipitates (Table 1).
This included both PfNAPs, many histones, and several
proteins involved in chromatin remodelling (ISWI,
CHD1, high mobility group protein, and structure-speci-
fic recognition protein). Interestingly, all recovered pro-
teins were members of the so-called ‘activating factors’ in
this pathway, whereas none of the ‘inactivating factors’
were present in the immunoprecipitates (see Additional
file 2, Figure A5), which again is consistent with the spe-
cificity of the approach. Some of these interactions were
validated by coupled co-immunoprecipitation/western-
blot analysis (see Additional file 2, Figure A6) and in
vitro kinase assays (Figure 5).
Both PfNap proteins were phosphorylated by recombi-
nant PfCK2a. In yeast, phosphorylation of Nap1by one of
the two catalytic subunits of CK2 is implicated in cell
cycle progression, as cells expressing CK2 phosphorylation
site Nap1 mutants display a lengthened S-phase and a
shortened G1 phase, together resulting in a delay in mito-
sis. Interestingly, these mutants retained the wild-type
ability to interact with histones [45]. It has been proposed
that phosphorylation of the PfNaps by human recombi-
nant CK2 may affect their affinity for histones [34]. PfCK2
might also act on PfNaps in vivo, thus affecting their func-
tion, and in accordance with this hypothesis, recent global
phosphoproteomic analyses of parasite extracts [46,47]
found both PfNaps be phosphorylated on acidic peptides
predicted to be CK2 substrates by the NetPhos tool
(Table 2).
We found that PfCK2a preferentially phosphorylated
histone H2B in vitro in a mixture of native histones
extracted from the parasite. Histone post-translational
modifications such as methylation and acetylation play
key roles in the control of expression of virulence genes
(for example, the var family) in malaria parasites [48])
Similarly, histone phosphorylation is known to play an
important regulatory role in other eukaryotes [49], and in
yeast, CK2 phosphorylates histone H4 at serine 1 as part
of a DNA damage-signaling pathway [50]. Although pre-
vious studies have identified few phosphorylation marks
in P. falciparum histones, we recently characterized sev-
eral novel phosphorylation marks on the parasite’s his-
tones (Dastidar et al., unpublished). Whether PfCK2 is
responsible for phosphorylation of any of these sites in
vivo, and the functional consequences of these phosphor-
ylation events, remain to be investigated. Nevertheless,
taken together, our data strongly suggest that PfCK2-
dependent phosphorylation may play a role in chromatin
dynamics.
We also tested other known nuclear proteins with a
potential role in gene regulation to see if they could be
substrates for the kinase. Of all the proteins tested,
recombinant PfAlba1 and PfAlba2 were found to be sub-
strates for the PfCK2a in vitro (Figure 5), and PfAlba1
was found to be phosphorylated in parasite extracts on
several residues [46,47], including one in an acidic stretch
consistent with CK2 substrate preferences (Table 2). By
contrast, recombinant PfAlba3, PfAlba4, and PfSir2 were
not phosphorylated by the kinase (Figure 5E). PfAlba1
and PfAlba2 belong to the same phylogenetic cluster,
which is distinct from that containing PfAlba3 and
PfAlba4 ([51,52]), consistent with their different ease if
phosphorylation by PfCK2. Moreover, the former two
PfAlbas possess an arginine- and glycine-rich RGG
domain in addition to the Alba domain. It has been
shown in S. cerevisiae that phosphorylation of the RGG
domains affects protein localization and transport
between the nucleus and cytoplasm [53]. Given that
PfAlba1 and PfAlba2 concentrate at the perinuclear
space in ring-stage parasites, but expand to the cytoplasm
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of trophozoites and schizonts [51], it is possible that
phosphorylation by PfCK2 may contribute to the regula-
tion of their nucleocytoplasmic transport.
Several proteins involved in mitosis and chromosome
separation and in DNA replication and DNA damage
pathways (for example, several replication factor C sub-
units, ATP-dependent DNA helicase, DNA ligase 1)
were also pulled down. Implication of CK2 in the DNA
damage response is well documented in other systems
[12], and a DNA repair pathway has been characterized
in P. falciparum [54], of which the DNA polymerase
and DNA ligase components can be retrieved in the
CK2b immunoprecipitates (see Additional file 3, Table
A2; see Additional file 4, Table A3; see Additional file 5,
Table A4). Because DNA repair is markedly reduced in
the highly drug-resistant W2 isolate, which displays a
higher rate of drug-resistance acquisition than do drug-
sensitive strains [55], it might be of interest to compare
CK2 activity in the W2 versus drug-sensitive clones.
Although many of the proteins identified in the immu-
noprecipitates were of nuclear origin, a number of poten-
tial interactors were associated with other cellular
compartments. Some of the recovered proteins were puta-
tive or established Maurer’s cleft proteins (for example,
Maurer’s cleft 2 transmembrane protein; Pfmc-2TM), pro-
teins involved in invasion and motility processes (for
example, glutamate-riche protein, merozoite surface pro-
tein 2 precursor, RhopH3, and other rhoptry-associated
proteins) or in cell-cell interaction processes (for example,
mature parasite-infected erythrocyte surface antigen,
PfEMP2 and rifins). Likewise, several proteins and
enzymes involved in redox metabolism were recovered
(thioredoxin, thioredoxin-related protein, thioredoxin per-
oxidase, glutathione peroxidase, glutathione S-transferase,
ribonucleotide reductase). This diversity is consistent with
our IFA, western blot, and immuno-EM data localizing all
the three subunits to both the nuclear and cytoplasmic
compartments. Although these results require confirma-
tion by other approaches, and despite the fact that we can-
not exclude false positives in our interactome list, they are
consistent with an involvement of PfCK2 kinase in varied
cellular functions in the parasite.
The availability of parasite lines expressing individual
tagged PKs for the almost entire P. falciparum kinome
[46] now allows implementation of a kinome-wide investi-
gation of kinase function based on the interactomics
approach used here for PfCK2. Preliminary data obtained
with other PKs suggest that distinct functions can there-
fore be assigned to different enzymes on the basis of speci-
fically pulled-down protein repertoires.
Conclusion
In conclusion, we have identified the PfCK2 complex as a
kinase distributed to different cellular compartments.
Our data point to PfCK2 as a pleiotropic kinase with var-
ious cellular functions. In this study, we explored poten-
tial nuclear functions of the kinase, and we propose a
role for PfCK2 in modifying a number of chromatin-
related proteins, several of which are also substrates for
the catalytic subunit of PfCK2 in vitro. Furthermore,
Table 2 Phosphopeptides identified in parasite extracts in two published phosphoproteome studies [46,47].a
Gene name PlasmoDB ID Phosphopeptideb NetPhos2
CK2 scorec
Ref
PfNapL PFL0185c EISSLLEsIKIDDDK [46]
PfNapL PFL0185c EISsLLESIK 0.842 [47]
PfNapL PFL0185c IDDDKMtDLTEEQK [46,47]
PfNapL PFL0185c VPNsNVIK [46,47]
PfNapS PFI0930c DRsENsVENTDPK [46,47]
PfNapS PFI0930c sDLDNEIPK 0.851 [47]
PfNapS PFI0930c HVtFDNNQEK [47]
PfNapS PFI0930c NPIAAVTHNRsDLDNEIPK [46]
PfAlba1 PF08_0074 MtNYVNYGAK [47]
PfAlba1 PF08_0074 CGsTVItDQYVsGQDNsEHVVQEK [47]
PfAlba1 PF08_0074 GSTVITDQYVsGQDNsEHVVQEK 0.602 [46]
PfAlba1 PF08_0074 EMtPEEIVNSR 0.727 [46,47]
PfAlba2 MAL13P1.233 NEDKKsGDEEEEEEEEEEDEENNK 0.991 [46]
PfAlba2 MAL13P1.233 PGsTKsDTKLENEIR [46]
PfAlba2 MAL13P1.233 sDtKLENEIR 0.772 [47]
PfH2B PF11_0062 YDsYGLYIFK [47]
PfH2B PF11_0062 sMNIMNsFLVDTFEK [47]
aPhosphosites predicted to be CK2 substrates by analysis using the KinasePhos2 tool http://kinasephos2.mbc.nctu.edu.tw/ are highlighted in bThe phosphosite in
the peptides are indicated by lowercase s or t. bold characters, and the score is indicated in the fourth column.
cOnly the sites experimentally shown to be phosphorylated are included here; note that there are additional predicted CK2 sites in these proteins.
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reverse genetics data show that all three subunits of the
kinase are essential for the viability of the blood-stage
parasite, confirming its potential as target for chemother-
apeutic intervention. This study paves the way for a
kinome-wide interactomics-based approach to elucidate
PK function in malaria parasites.
Methods
Construction of the knockout plasmids pCAM-BSD-
KOPfCK2b1 and pCAM-BSD-KOPfCK2b2
Fragments from central region of the PfCK2b1 and
PfCK2b2 ORFs were amplified by PCR and inserted
between the BamHI and NotI sites of the pCAM-BSD
plasmid [31], which contains the Aspergillus terreus
blasticidin-S-deaminase gene, whose gene product con-
fers resistance to blasticidin (see Additional file 1, table
A1, for cloning primers).
Construction of the complementation plasmids pCHD-
PfCK2b1 and pCHD-PfCK2b2
A plasmid for in vivo episomal expression of PfCK2b1 and
PfCK2b2 subunits were constructed as follows. The full-
length coding sequences were first inserted between the
BglII and NotI sites of plasmid pHGB [56], and then trans-
ferred into plasmid pCHD-1/2 [56] by a clonase reaction
(Gateway system, Invitrogen) according to the manufac-
turer’s instructions. Plasmid pCHD-1/2 includes a cassette
encoding human dihydrofolate reductase, conferring resis-
tance to the antifolate drug WR99210. Parasites that were
transfected with both a KO plasmid and a complementa-
tion plasmid were cultured under double-drug selection
(see below).
3’-tagging of plasmids
The 3’ end of the PfCK2b2 coding sequence (573 bp,
omitting the stop codon) was amplified by PCR using pri-
mers incorporating PstI and BamHI restriction sites and
inserted between the same sites of the pCAM-BSD-HA
plasmid [57]. For pfCK2b1, the 3’ end of the gene (540 bp)
was amplified, then the PCR product was treated with the
restriction enzymes PstI and BglII and inserted between
the PstI and BamHI sites of pCAM-BSD-HA.
Parasite culture and transfection
Four P. falciparum strains (3D7A [58] and three HA-
tagged strains of PfCK2 subunits: PfCK2aHA,
PfCK2b1HA and PfCK2b2HA) [19] were grown in human
erythrocytes as described previously [59]. The medium for
the HA-tagged lines was supplemented with blasticidin
(2.5 μg/ml; VWR International Ltd., West Chester, PA,
USA). Cultures of the P. falciparum clone 3D7A were
maintained at 37°C in RPMI 1640 medium (Gibco) sup-
plemented with 25 mmol/l sodium bicarbonate, 2 mmol/l
L-glutamine, 300 mmol/l hypoxanthine, 10 μg/ml
gentamicin, and lipid-rich bovine serum albumin (BSA)
(AlbuMAX II; Sigma-Aldrich, St Louis, MO, USA).
Cultures were seeded at 5% hematocrit volume and main-
tained at a parasitemia of 1 to 10% with daily changes of
medium. The incubator was flushed with a gas mixture
containing 5% CO2. For transfection, asexual blood-stage
parasites were synchronized by sorbitol treatment [60] so
as to result in the majority being ring-stage parasites.
Forty-eight hours later, the ring-stage parasites were trans-
fected by electroporation with 100 μg of purified plasmid
DNA in buffer (Cytomix; Gibco-BRL, Grand Island, New
York, NY, USA) as described previously [61]. Blasticidin
(2.5 μg/ml) was added to the culture medium to select for
transformed parasites. Parasites under double selection
had 5 nmol/l WR99210 added to the culture medium in
addition to blasticidin. Parasites were maintained in this
supplemented medium from 2 days post-transfection.
DNA extraction and Southern blotting
Parasite cultures were lysed in 0.15% saponin. The para-
site pellets were resuspended in cold phosphate-buffered
saline, and treated with 150 μg/ml proteinase K and 2%
SDS at 55°C for 2 to 3 hours. Total DNA was extracted
in phenol:chloroform:isoamyl alcohol (25:24:1) and pre-
cipitated in ethanol and 0.3 mol/l sodium acetate. DNA
was digested with ClaI and EcoRI for PfCK2b1, and
with ClaI and NcoI for PfCK2b2.
Western-blot analysis
Cytoplasmic and nuclear extracts were prepared as
described previously [41,62]. Using standard procedures.
SDS-PAGE was performed and DNA was transferred to
nitrocellulose membranes, which were probed using
either commercially available antibodies against HA-tag
(ab9110; 1:1000 dilution), histone H3 (ab1791; 1:2500
dilution), P. falciparum aldolase (ab38905; 1:1000) (all
Abcam, Cambridge, MA, USA) or subunit-specific anti-
bodies generated in rabbits against the PfCK2b1-derived
peptide DSNKDLQDSKSDKS (1:500 dilution) or the
PfCK2b2-derived peptide DEINRDSEEMYKNK (1:1000
dilution (both BioGenes GmBH, Berlin, Germany) After
probing with appropriate secondary antibodies conju-
gated to horseradish peroxidase (GE Healthcare Life
Sciences, Princeton, NJ, USA), the membranes were
developed with a commercial substrate (Super Signal
West Pico Chemiluminescent Substrate; Thermo Fisher
Scientific Inc., Rockford, IL, USA) in accordance with
the manufacturer’s recommendations.
Immunofluorescence assays
IFAs were performed on synchronized stages (ring, tro-
phozoite, and schizont) of the three HA-tagged strains of
the PfCK2 subunits as described previously [56]. The fixed
cells were incubated with primary antibodies anti-HA
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(ab9110; 1:2000 dilution) and anti-Exp2 [32] (1:800 dilu-
tion) (both Abcam). After incubating with appropriate sec-
ondary antibodies, the cells were examined under a
microscope (Nikon Instruments, Tokyo, Japan).
Immuno-gold electron microscopy
Infected erythrocytes were fixed in 1% glutaraldehyde in
RPMI-HEPES buffer for 1 hour at 4°C. After washing,
polymerization in agar (Type IX; Sigma-Aldrich), and
dehydration with ethanol, the samples were transferred
into embedding resin (LR-White; London Resin Com-
pany Ltd, Reading, Berkshire, UK), and polymerized for
12 hours at 4°C, and cut. Ultrathin sections of the sam-
ple were collected and mounted on Cu/Pd grids. Free
aldehyde groups were blocked by incubating the samples
for 5 minutes in 50 mmol/l NH4Cl. Sections were
blocked in phosphate-buffered saline containing 5% (v/
v) normal goat serum, 1% (w/v) BSA and 0.01% (v/v)
Tween-80. The washed grids were incubated for 2 hours
in antiserum diluted in phosphate-buffered saline con-
taining 1% (v/v) normal goat serum, 1% (w/v) BSA and
0.01% (v/v) Tween-80 and anti-HA antibody (ab9110;
Abcam). Samples were washed and incubated for 45
minutes with 12-nm gold-labeled goat anti-rabbit IgG
(111-205-144; Jackson Immunoresearch Laboratories,
Inc., West Grove, PA, USA). Washed sections were
stained for 15 minutes with aqueous 4% uranyl acetate
followed by staining for 2 minutes with 1% lead citrate.
Sections were analyzed using an electron microscope
(JEM-1200EX; JEOL Ltd, Tokyo, Japan) at 120 kV.
Parasite proteins extraction and immunoprecipitation
Parasite cultures were lysed in 0.15% saponin and pellets
were stored at -80°C. Proteins were extracted on ice using
mammalian protein extraction reagent (M-PER) (Pro-
found™ Mammalian HA-tag IP/Co-IP application;
Thermo Fisher Scientific) with protease inhibitors (1:25;
Complete Protease Inhibitor Cocktail; Roche Diagnostics,
Basel, Switzerland) and benzonase nuclease (1:500; Nova-
gen, Darmstadt, Germany). The lysates were cleared by
centrifugation at 11,180 g for 15 minutes at 4°C, and the
concentration of proteins measured by the Bradford assay.
Proteins were loaded on a spin column with a pre-inserted
frit, preventing bead loss between washes, and 6 μl (50%
v/v_ of anti-HA crosslinked onto sepharose beads were
added (both included in the kit used for protein extraction;
Thermo Fisher Scientific). The columns were then trans-
ferred to a rocker platform and incubated overnight. The
flow-through was collected by centrifugation at 300 g for
10 seconds at room temperature. The columns were
washed three times using the Tris-buffered saline (TBS)
provided in the kit, followed by a short burst of centrifuga-
tion (300 g for 10 seconds). Finally, any proteins bound to
the beads were eluted using boiled 4× Laemmli buffer, and
recovered by centrifugation (15,600 g for 3 minutes). Ali-
quots of protein extracts and flow-through liquid were
taken before and after immunoprecipitation to monitor
the yield.
Mass spectrometry analysis
Samples were separated by SDS-PAGE on 10% polyacryla-
mide gel, which was then stained with Coomassie blue
(Biosafe; Bio-Rad Laboratories, Inc., Hercules, CA, USA),
and later placed in 10% ethanol and 1% acetic acid. Each
lane was removed from the gel and cut into eight slices,
then the proteins were digested in the gel using trypsin As
follows. Briefly, the samples were reduced in 10 mmol/l
dithioerythritol (DTE) and alkylated in 55 mmol/l iodoace-
tamide (IAA), the gel pieces were dried. The samples were
incubated with 12.5 ng/ml trypsin overnight at 37°C. The
tryptic peptides were extracted from the gel slices, dried,
and resuspended in 2% acetonitrile (ACN):0.1% formic
acid (FA) for liquid chromatography/tandem mass spec-
trometry (LC-MS-MS) analysis
A mass spectrometer (LTQ Orbitrap XL (Thermo
Fischer Scientific) equipped with an ultraperformance LC
(UPLC) system (NanoAcquity; Waters Ltd, Elstree, Hert-
fordhshire, UK) was used. Peptides were trapped in a cus-
tom-made precolumn (Magic C18 AQ stationary phase,
5 μm diameter, 200Å pore, 0.1 × 20 mm, Michrom Biore-
source) and separated in a custom-made main column
(Magic C18 AQ, 3 μm diameter, 100Å pore, 0.75 × 150
mm), using a run of 53 minutes and a gradient of H2O:
ACN:FA 98%:2%:0.1% (solvent A) and ACN:H2O:FA
98%:1.9%:0.1% (solvent B). The gradient was run at a flow
rate of 250 nl/min as follows: 100% A for 3 min, 30% B
within 36 min, 47% B within 14 min, 90% B within 5 min
held for 5 min and 100% A for 17 min. The MS/MS was
operated in an information-dependent mode, in which
each full MS analysis was followed by 10 MS/MS acquisi-
tions, during which the most abundant peptide were
selected for collision-induced dissociation (CID) to gener-
ate tandem mass spectra. The normalized collision ener-
gies were set to 35% for CID.
Data search was performed using Mascot software
(version 2.3; Matrix Science Inc., Boston, MA, USA) and
Proteome Discoverer (v.1.1; Thermo Fisher Scientific),
and the sequences searched against a concatenated data-
base consisting of non-redundant Plasmodium database
(PlasmoDB, version 6.4; http://plasmodb.org) and the
reversed-sequence version of the same database and
common contaminant proteins. Finally, results were
imported into Scaffold (version 3_00_8 Proteome Soft-
ware; http://proteomesoftware.com/) for validation of
protein identification, normalization, and comparison of
spectral count. Peptide identifications were accepted if
they could be established at a probability of greater than
95% as determined by the ProteinProphet algorithm
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[63]. Protein identifications were accepted if they were
assigned at least two unique, validated peptides, and
could be established with at least 99% probability as
determined by the ProteinProphet algorithm [64].
Kinase assays
The GST-PfCK2a and GST-PfCK2a-dead K72M mutant
fusion proteins [19] were purified from E. coli (BL21
Gold strain) as described previously [65]. PfCK2a kinase
activity was determined by measuring 33P or 32P incor-
poration using g[33P]-ATP or g[32P]-ATP. All the sub-
strates (Alba1, Alba2, Alba3, Alba4, PfSir2; kindly
provided by C. Scheidig-Benatar), and extracted P. falci-
parum histones were treated with active PfCK2a and
dead mutant as described previously [65]. Samples were
run on a 16% gel, which was dried and exposed to film
for autoradiography.
Additional material
Additional file 1: Additional Table A1. Table of primers used in this
study.
Additional file 2: Additional Figures A1-A6. Additional Figures A1-A6
and their legends.
Additional file 3: Additional Table A2. List of proteins identified by
mass spectrometry analysis of protein complexes immunoprecipitated
from the parasite line expressing hemagglutinin-tagged PfCK2b1.
Additional file 4: Additional Table A3. List of proteins identified by
mass spectrometry analysis of protein complexes immunoprecipitated
from the parasite line expressing hemagglutinin-tagged PfCK2b2.
Additional file 5: Additional Table A4. Mass spectrometry data from
immunoprecipitates obtained with PfCK2b1 and PfCK2b2 hemagglutinin-
tagged transgenic lines, highlighting the significant overlap in the
identity of recovered proteins, and the occurrence of potential
interactors that are unique to either PfCK2 regulatory subunit. Note that
the data are not sufficient to draw statistically supported conclusions
about the possible restriction of proteins to the interactome list of one
or the other b subunit, and that this table must be considered as a
preliminary dataset only.
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